Tri Locum Partners’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-200,000	Closed	-$3.33M	–	80
2023 Q1	$3.33M	Buy	+200,000	New	+$3.33M	1.01%	30